Searched for
GILEAD SCIENCES INC
India's shortage of remdesivir is easing, Goa plant to ramp up production: CiplaRemdesivir, made by U.S.-based Gilead Sciences Inc, has been in high demand globally, and a handful of companies including Cipla are author...11 Aug, 2020, 08.28 PM IST- India's Zydus Cadila to make Gilead's potential COVID-19 drug remdesivirZydus, listed as Cadila Healthcare, joins other Indian pharmaceutical companies Cipla Ltd, Jubilant Sciences Ltd and privately held Hetero ...12 Jun, 2020, 09.56 PM IST
- Gilead under gun to mass-produce virus drug or risk exclusivityAll of that could add up to market wins if remdesivir lives up to expectations and Gilead can ramp up to sufficiently respond to Covid-driv...08 May, 2020, 12.46 AM IST
- Gilead's antiviral drug remdesivir flops in first trialThe Chinese trial showed the antiviral remdesivir did not improve patients' condition or reduce the pathogen's presence in the bloodstream,...23 Apr, 2020, 10.31 PM IST
- Gilead to buy Kite for $11.9 billion in cancer drug megadealWith Kite, Gilead will gain cancer therapies and experimental drugs in one of the most promising fields in oncology, in addition to its hep...28 Aug, 2017, 11.38 PM IST
- Natco settles patent suit with Gilead, others over TamifluNatco Pharma and its partner Alvogen today said they have settled patent infringement suit with Gilead Sciences Inc and others over Tamiflu.14 Dec, 2015, 11.37 AM IST
- Dr Reddy's to launch Hepatitis C drug in IndiaSofosbuvir is a medicine used for chronic Hepatitis C infection and sold globally by Gilead Sciences Inc, under its brand Sovaldi.23 Mar, 2015, 06.21 PM IST
- Zydus Cadila launches Gilead's Hepatitis C drug in IndiaSofosbuvir is a medicine used for chronic hepatitis C infection and sold globally by Gilead Sciences Inc, under its brand Sovaldi.17 Mar, 2015, 04.19 PM IST
- Natco Pharma ties up with Gilead on hepatitis C drugsNatco will fix its own price for the generic versions, and will pay a royalty on sales to Gilead, the company said.02 Mar, 2015, 12.32 PM IST
- Strides Arcolab inks pact with Gilead Sciences for HIV drugStrides has entered into a licensing agreement with Gilead to manufacture and distribute latter's low-cost TAF used for HIV treatment in de...20 Jan, 2015, 01.03 PM IST
- Gilead to challenge hepatitis C drug patent rejection decision"The main patent applications covering sofosbuvir are still pending before the Indian Patent Office," Alton said.16 Jan, 2015, 02.14 PM IST
- Gilead's hepatitis C drug licensing to benefit more patients: SitharamanA delegation of Gilead Sciences Inc yesterday met Commerce and Industry Minister Nirmala Sitharaman and informed about the signing of non-e...17 Sep, 2014, 04.12 PM IST
- CCI rules out case against Gilead SciencesCCI has rejected a complaint against Gilead Sciences Inc that alleged the US-based pharmaceutical company of abusing its dominant position.12 Mar, 2013, 02.46 PM IST
- Strides Arcolab inks pact with Gilead Sciences to promote HIV drugStrides has inked a pact with Gilead Sciences Inc to sell low-cost generic versions of latter's HIV medicine 'emtricitabine' in developing ...06 Aug, 2012, 02.49 PM IST
- Ranbaxy inks pact with Gilead for three generic HIV/AIDS drugsRanbaxy has entered into an agreement with US-headquartered Gilead Sciences to manufacture and market three new generic HIV/AIDS drugs.12 Jul, 2011, 02.47 PM IST
- Aids drug prices to fall if Gilead fails to defend patent applicationPrice of a crucial AIDS drug may fall further if Cipla and AIDS patients succeed in their challenge to a patent application filed here by U...15 May, 2007, 02.21 AM IST
- Ranbaxy in pact with Gilead for 'Tenofovir'Ranbaxy Laboratories Ltd said on Monday that it has entered into a licensing agreement with US-based Gilead Sciences Inc for manufacturing ...25 Sep, 2006, 12.05 PM IST
Load More
